CN1113157A - Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation - Google Patents

Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation Download PDF

Info

Publication number
CN1113157A
CN1113157A CN 95103142 CN95103142A CN1113157A CN 1113157 A CN1113157 A CN 1113157A CN 95103142 CN95103142 CN 95103142 CN 95103142 A CN95103142 A CN 95103142A CN 1113157 A CN1113157 A CN 1113157A
Authority
CN
China
Prior art keywords
rheumatoid arthritis
medicine
treatment
finished product
electuary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95103142
Other languages
Chinese (zh)
Inventor
赵华明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 95103142 priority Critical patent/CN1113157A/en
Publication of CN1113157A publication Critical patent/CN1113157A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invented drug for treatment of rheumatoid arthritis is a powder preparation, and its ingredients are the dried stem of Orientvine (sinomenium Acutum), dried stem and leaf of Hairy Grape, Wupifeng (a Chinese herbal medicine, used for treating rheumatic arthritis, articular swelling and pain) and sarcandra. The invented drug has the notable functions of relieving inflammation, alleviating pain and subduing swelling for curing rheumatoid arthritis, and its cure rate can be up to above 50%, and its total effective rate is 92.5%. Besides, it also has the notable curative effect for migratory arthralgia and rheumatic disease, and has no any toxic side effect, and is safe and can be taken for a long period.

Description

Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation
The present invention relates to the manufacture method of a kind of medicine and electuary thereof, particularly a kind of manufacture method for the treatment of the medicine and the electuary thereof of rheumatoid arthritis.
The medicine of treatment rheumatoid arthritis is more at present, alleviates condition of illness but effect mainly is pain relieving, just cures the symptoms, not the disease, and curative effect is all difficult to comply with one's wishes, and can not reach the effect of healing, and toxic and side effects is more obvious.
The objective of the invention is to: a kind of manufacture method that can fundamentally treat the medicine and the electuary thereof of rheumatoid arthritis disease is provided.This medicine has significant pain relieving, antiinflammatory, detumescence effect to treatment rheumatoid arthritis disease.This medicine is without any side effects, and drug safety can be taken for a long time.
Embodiment of the present invention are that drug component comprises: PAIFENGTENG, Herba Anemones vitifoliae, five wind, swollen knotweed.
The weight proportion of described component can be: PAIFENGTENG 30-50%, Herba Anemones vitifoliae 20-40%, five wind 10-20%, swollen knotweed 10-20%.
The manufacture method of the medicine instant of treatment rheumatoid arthritis disease is, PAIFENGTENG, Herba Anemones vitifoliae, five wind, the swollen knotweeds that prepare are merged decoct, medicinal liquid; In medicinal liquid, add white sugar, dextrin receipts lamb, granulate, get the electuary finished product.
In the described electuary finished product, contain white sugar 40%, contain dextrin 40-45%, containing the crude drug composition is 15-20%.Described electuary finished product dosage is: each 10~20 grams, every day 2-3 time.
Compared with the prior art, the present invention is owing to be fundamentally to treat rheumatoid arthritis disease, and drug component is reasonable, treatment rheumatoid arthritis disease there are significant pain relieving, antiinflammatory, repercussive effect, cure rate height, cure rate are more than 51%, and total effective rate is 92.5%.In addition, gout, rheumatism etc. also there is tangible curative effect.And without any side effects, drug safety can be taken for a long time.
Embodiment 1: get the PAIFENGTENG of crude drug total amount 40%, 30% Herba Anemones vitifoliae, five wind of 15%, 15% swollen knotweed merging decoction, get the decocting medicinal liquid; This decocting medicinal liquid can directly be taken; Also can in medicinal liquid, add white sugar, dextrin receipts lamb, granulate, make the electuary finished product.
In the described electuary finished product, component can be white sugar 40%, dextrin 45%, and containing the crude drug composition is 15%.Described electuary finished product dosage is: each 10 grams, every day 3 times.
Embodiment 2: get the PAIFENGTENG of crude drug total amount 50%, 25% Herba Anemones vitifoliae, five wind of 15%, 10% swollen knotweed merging decoction, get the decocting medicinal liquid; This decocting medicinal liquid can directly be taken; Also can in medicinal liquid, add white sugar, dextrin receipts lamb, granulate, make the electuary finished product.
In the described electuary finished product, component can be white sugar 40%, dextrin 40%, and containing the crude drug composition is 20%.Described electuary finished product dosage is: each 20 grams, every day 2 times.
Medicine of the present invention is made water decoction and is taken, and the potion dosage is the 15-30 gram, and medicine of the present invention in addition also can be made into other forms such as pill, capsule and takes.

Claims (5)

1, the medicine of treatment rheumatoid arthritis is characterized in that component comprises: PAIFENGTENG, Herba Anemones vitifoliae, five wind, swollen knotweed.
2, the medicine of treatment rheumatoid arthritis according to claim 1 is characterized in that, the weight proportion of described component is: PAIFENGTENG 30-50%, Herba Anemones vitifoliae 20-40%, five wind 10-20%, swollen knotweed 10-20%.
3, the medicine instant manufacture method of treatment rheumatoid arthritis is characterized in that:
A, the PAIFENGTENG with preparing, Herba Anemones vitifoliae, five wind, swollen knotweeds merge decoction, get medicinal liquid;
B, in medicinal liquid, add white sugar, dextrin and receive lamb, granulate, the electuary finished product.
4, the electuary manufacture method of the medicine of treatment rheumatoid arthritis according to claim 3 is characterized in that: in the described electuary finished product, contain white sugar 40%, contain dextrin 40-45%, containing the crude drug composition is 15-20%.
5, the medicine instant manufacture method of treatment rheumatoid arthritis according to claim 4 is characterized in that: described electuary finished product dosage is: each 10~20 grams, every day 2-3 time.
CN 95103142 1995-03-23 1995-03-23 Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation Pending CN1113157A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95103142 CN1113157A (en) 1995-03-23 1995-03-23 Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95103142 CN1113157A (en) 1995-03-23 1995-03-23 Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation

Publications (1)

Publication Number Publication Date
CN1113157A true CN1113157A (en) 1995-12-13

Family

ID=5074609

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95103142 Pending CN1113157A (en) 1995-03-23 1995-03-23 Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation

Country Status (1)

Country Link
CN (1) CN1113157A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770058A (en) * 2016-04-11 2016-07-20 山东省文登整骨医院 Traditional Chinese medicine composition for treating orthopedic diseases and preparation method and application thereof
CN106265851A (en) * 2016-08-31 2017-01-04 贵州苗侗古方民族医药开发有限公司 A kind of Seedling tea of effective reduction uric acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770058A (en) * 2016-04-11 2016-07-20 山东省文登整骨医院 Traditional Chinese medicine composition for treating orthopedic diseases and preparation method and application thereof
CN106265851A (en) * 2016-08-31 2017-01-04 贵州苗侗古方民族医药开发有限公司 A kind of Seedling tea of effective reduction uric acid

Similar Documents

Publication Publication Date Title
CN1116528A (en) Chinese drug for treating sciatica and gout
CN1113157A (en) Preparation method for medicine for treatment of rheumatoid arthritis and its powder preparation
CN1159347A (en) Traditional Chinese medicine Jinjiangkebao for treating cough
CN1065133C (en) External use medicine for curing acne
CN1087243A (en) Health drink
CN1243556C (en) Toxicity expelling wind damping joint curing wine
CN1251764A (en) Exterior-applied ointment for treating rheumatic arthritis
CN1052906C (en) External application medicine for treating toothache due to saprodontia
CN1106696A (en) Chinese herbal medicine hepatitis B recovering agent and its preparing method
CN1310665C (en) Medicine for treating deaf-mutism
CN1273167C (en) Medicine for external application for curing rheumatism and its preparation method
CN1473611A (en) Rheumatism paste and its preparing method
CN1517106A (en) Medicinal wine for treating rheumatic arthritis
CN1057926C (en) Medicinal composition for curing gastrointestinal disease
CN1064844C (en) Chinese medicine
CN1118268A (en) Medicine for parotitis and its preparation
CN1073097A (en) A kind of method for making of rheumatoid disease application compress
CN1065437C (en) Traditional Chinese medicine prescription for treating ischialgia disease
CN1062757C (en) Pregrant powder and preparing method therefor
CN1060354C (en) External-use medicine liquid 'Bishikang' for curing rhinitis
CN111773327A (en) Chinese medicinal composition for improving eyesight
CN1279085A (en) Process for preparing medicine to cure rheumatic or rheumatoid arthritis
CN1288745A (en) Preparation of externally applied Chinese medicine
CN1214923A (en) Medicine for curing palsy and hypertension and preparation process thereof
CN1733087A (en) Cold quick stopping capsule and preparation process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication